JY
IGC icon

Jeff Yass’s IGC Pharma IGC Stock Holding History

Jeff Yass’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.94K Buy
+14,600
New +$4.32K ﹤0.01% 13206
2025
Q4 		– Sell
-12,100
Closed -$5.08K – 12921
2025
Q3 		$5.08K Buy
+12,100
New +$4.6K ﹤0.01% 12131
2024
Q1 		– Sell
-15,900
Closed -$4.45K – 12689
2023
Q4 		$4.45K Sell
15,900
-100
-0.6% -$31 ﹤0.01% 12133
2023
Q3 		$5.76K Sell
16,000
-2,500
-14% -$894 ﹤0.01% 11774
2023
Q2 		$5.74K Sell
18,500
-100
-0.5% -$32 ﹤0.01% 11814
2023
Q1 		$6.32K Sell
18,600
-6,400
-26% -$2.4K ﹤0.01% 12277
2022
Q4 		$8K Sell
25,000
-10,700
-30% -$4.36K ﹤0.01% 11971
2022
Q3 		$15K Sell
35,700
-20,100
-36% -$10.7K ﹤0.01% 12697
2022
Q2 		$30K Sell
55,800
-20,900
-27% -$13.2K ﹤0.01% 12220
2022
Q1 		$73K Buy
76,700
+55,300
+258% +$53.7K ﹤0.01% 12104
2021
Q4 		$21K Sell
21,400
-90,000
-81% -$121K ﹤0.01% 12817
2021
Q3 		$165K Sell
111,400
-84,300
-43% -$136K ﹤0.01% 11705
2021
Q2 		$321K Buy
195,700
+35,800
+22% +$54.6K ﹤0.01% 10629
2021
Q1 		$286K Buy
159,900
+92,200
+136% +$167K ﹤0.01% 10708
2020
Q4 		$106K Buy
67,700
+32,300
+91% +$47.7K ﹤0.01% 10467
2020
Q3 		$37K Buy
+35,400
New +$36K ﹤0.01% 10277
2019
Q2 		– Sell
-34,500
Closed -$72K – 10502
2019
Q1 		$72K Buy
+34,500
New +$78.4K ﹤0.01% 8375

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM

Jeff Yass's IGC Position: Q2 2026 in Review

Jeff Yass reduced its IGC Pharma (IGC) stake by 76% in Q2 2026, selling an estimated $27.7K and leaving 28,882 shares worth $7.86K. The position accounts for ﹤0.01% of the portfolio, ranked #13162.

Jeff Yass first reported a position in IGC in Q1 2016 and has held it in 27 quarters since. The position peaked at $878K in Q1 2021. 36 funds tracked by Wall St. Rank hold IGC as of Q2 2026.

  • Jeff Yass held 28,882 shares of IGC Pharma worth $7.86K as of Q2 2026.
  • Jeff Yass sold 93,713 IGC Pharma shares in Q2 2026, an estimated $27.7K.
  • IGC Pharma made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #13162 holding.
  • Jeff Yass first reported a position in IGC Pharma in Q1 2016 and has held it in 27 quarters since.
  • Jeff Yass's IGC Pharma position peaked at $878K in Q1 2021.
  • 36 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.